Personal Information
Organización/Lugar de trabajo
Moscow, Russian Federation Russian Federation
Ocupación
CEO @ Synergy CRO
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.synrg-pharm.com
Acerca de
Russia’s success as a clinical trial market is driven by three factors which are crucial for each and every study: high patient recruitment rate, reasonable costs at a fraction of US and European and excellent data quality confirmed by 100+ FDA inspections. This is what we call the Troika Promise - Speed, Cost and Quality.
Etiquetas
clinical trials
clinical research russia
clinical research
clinical trials russia
risk based monitoring
risk management
rbm
#blockchain
#russia
technology
innovation
blockchain
synergy cro
#tokenization
#cryptocurrency
#bitcoin
#regulations
#mining
statistics
#centralmonitoring
#rbm
#realrbm
#riskbasedmonitoring
foresight
study budgeting
project management
patient recruitment
pharmaceutical r&d
agile drug development
drug development
orange paper
drug research russia
russia
clinical trial regulations
regulatory
Ver más
Presentaciones
(19)Documentos
(4)Personal Information
Organización/Lugar de trabajo
Moscow, Russian Federation Russian Federation
Ocupación
CEO @ Synergy CRO
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.synrg-pharm.com
Acerca de
Russia’s success as a clinical trial market is driven by three factors which are crucial for each and every study: high patient recruitment rate, reasonable costs at a fraction of US and European and excellent data quality confirmed by 100+ FDA inspections. This is what we call the Troika Promise - Speed, Cost and Quality.
Etiquetas
clinical trials
clinical research russia
clinical research
clinical trials russia
risk based monitoring
risk management
rbm
#blockchain
#russia
technology
innovation
blockchain
synergy cro
#tokenization
#cryptocurrency
#bitcoin
#regulations
#mining
statistics
#centralmonitoring
#rbm
#realrbm
#riskbasedmonitoring
foresight
study budgeting
project management
patient recruitment
pharmaceutical r&d
agile drug development
drug development
orange paper
drug research russia
russia
clinical trial regulations
regulatory
Ver más